Mucormycosis and COVID-19: Double trouble for India?

J Glob Health. 2022 Feb 12:12:03001. doi: 10.7189/jogh.12.03001. eCollection 2022.

Authors

Farah Yasmin¹, Hala Najeeb¹, Sarush Ahmed Siddiqui¹, Rohan Kumar Ochani¹

Affiliation

¹ Department of Internal Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.

No abstract available

MeSH terms

COVID-19*
Humans
India / epidemiology
Mucormycosis* / epidemiology
Risk Factors
SARS-CoV-2